Showing results (41-50 of 59) with videos related to
Sort By:
Pageof 6
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 31, 2025
Tolerability and safety of a new oral device for prevention and treatment of oral mucositis in patients with hematologic malignancies undergoing chemotherapyArtem Oganesyan, Lusine Harutyunyan, Araksya Vanoyan, et al.Nucleic Acids Research|October 5, 2017
Enrichment of dynamic chromosomal crosslinks drive phase separation of the nucleolusCaitlin Hult, David Adalsteinsson, Paula A Vasquez, et al.Nature|June 26, 2010
Structure and mechanism of human DNA polymerase etaChristian Biertümpfel, Ye Zhao, Yuji Kondo, et al.Vaccines|August 26, 2022
Satisfaction with COVID-19 Vaccines in Health Care Workers and the General Population: A Cross-Sectional Study in Urban Bangkok, ThailandJadsada Kunno, Pataraporn Yubonpunt, Chavanant Sumanasrethakul, et al.Clinical Biomechanics (Bristol, Avon)|May 1, 2021
Does the impaired postural control in Parkinson's disease affect the habituation to non-sequential external perturbation trials?Victor Spiandor Beretta, Mark Gregory Carpenter, Fabio Augusto Barbieri, et al.Critical Care (London, England)|March 28, 2013
Sepsis biomarkers in unselected patients on admission to intensive or high-dependency careMartin J Llewelyn, Mario Berger, Mark Gregory, et al.Journal of Proteomics|February 19, 2013
The PI(3)P interactome from a colon cancer cellBruno Catimel, Eugene Kapp, Meng-Xin Yin, et al.Lab on a Chip|September 15, 2017
Detection of membrane-bound and soluble antigens by magnetic levitationMikkel Schou Andersen, Emily Howard, Shulin Lu, et al.Frontiers in Oncology|July 11, 2026
Clinical efficacy and safety of pembrolizumab and nivolumab in frontline treatment for classical Hodgkin lymphoma: systematic review and meta-analysis of clinical trialsArtem Oganesyan, Andrew Gregory, Mark Gregory, et al.Journal for Immunotherapy of Cancer|March 27, 2026
Pharmacologic targeting of the dopamine D2 receptor impacts the efficacy of immune checkpoint blockade in melanomaMark Gregory, Justin B Hackett, Savannah Hughes, et al.Pageof 6